854085-71-5

Basic information

• Product Name: Benzothiazole, 6-mercapto- (5CI)
• Synonyms: Benzothiazole, 6-mercapto- (5CI)
• CAS NO: 854085-71-5
• Molecular Formula: C7H5NS2
• Molecular Weight: 167.2513
• Product Categories: BENZOTHIAZOLE
• Mol File: 854085-71-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 300.1±15.0 °C(Predicted)
• Appearance: /
• Density: 1.407±0.06 g/cm3(Predicted)
• PKA: 5.47±0.30(Predicted)
• CAS DataBase Reference: Benzothiazole, 6-mercapto- (5CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzothiazole, 6-mercapto- (5CI)(854085-71-5)
• EPA Substance Registry System: Benzothiazole, 6-mercapto- (5CI)(854085-71-5)

Safety Data

• Hazardous Substances Data: 854085-71-5(Hazardous Substances Data)

Upstream product

• 53218-26-1 6-bromo-1,3-benzothiazole 

Relevant articles and documents

NOVEL GALACTOSIDE INHIBITOR OF GALECTINS

The present invention relates to a D-galactopyranose compound of formula (1) wherein the pyranose ring is α-D-galactopyranose, and these compounds are high affinity galectin-1 and/or galectin 3 inhibitors for use in treatment of inflammation; fibrosis; scarring; keloid formation; aberrant scar formation; surgical adhesions; septic shock; cancer; metastasising cancers; autoimmune diseases, metabolic disorders; heart disease; heart failure; pathological angiogenesis; eye diseases; atherosclerosis; metabolic diseases; diabetes type I; diabetes type II; insulin resistance; Diastolic heart failure; asthma; liver disorders.

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.